Mereo BioPharma Group plc (MPH.L) (LON:MPH) Stock Passes Below 50-Day Moving Average of $26.50

Mereo BioPharma Group plc (MPH.L) (LON:MPH)’s stock price passed below its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of GBX 26.50 ($0.33) and traded as low as GBX 26 ($0.32). Mereo BioPharma Group plc (MPH.L) shares last traded at GBX 26.50 ($0.33), with a volume of 49,264 shares changing hands.

Mereo BioPharma Group plc (MPH.L) Price Performance

The company has a debt-to-equity ratio of 164.26, a quick ratio of 2.92 and a current ratio of 2.98. The company’s 50 day moving average price is GBX 26.50 and its 200 day moving average price is GBX 26.50. The company has a market cap of £89.76 million and a price-to-earnings ratio of -0.21.

Mereo BioPharma Group plc (MPH.L) Company Profile

Mereo BioPharma Group plc, a biopharmaceutical company, acquires, develops, and commercializes therapeutics for the treatment of oncology and rare diseases. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the treatment of tumor.